These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22630150)

  • 1. In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy.
    Rojnik M; Kocbek P; Moret F; Compagnin C; Celotti L; Bovis MJ; Woodhams JH; Macrobert AJ; Scheglmann D; Helfrich W; Verkaik MJ; Papini E; Reddi E; Kos J
    Nanomedicine (Lond); 2012 May; 7(5):663-77. PubMed ID: 22630150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(D, L-lactide-co-glycolide) nanoparticles as delivery agents for photodynamic therapy: enhancing singlet oxygen release and photototoxicity by surface PEG coating.
    Boix-Garriga E; Acedo P; Casadó A; Villanueva A; Stockert JC; Cañete M; Mora M; Sagristá ML; Nonell S
    Nanotechnology; 2015 Sep; 26(36):365104. PubMed ID: 26293792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
    Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
    Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
    Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
    Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.
    Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD
    Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma.
    Liang C; Yang Y; Ling Y; Huang Y; Li T; Li X
    Bioorg Med Chem; 2011 Jul; 19(13):4057-66. PubMed ID: 21641806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of PEG-PLGA-PEG nanoparticles-based multipolyplexes for IL-18 gene delivery.
    Nie Y; Zhang ZR; He B; Gu Z
    J Biomater Appl; 2012 May; 26(8):893-916. PubMed ID: 21273262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
    Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
    J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
    Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
    Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake mechanism of furosemide-loaded pegylated nanoparticles by cochlear cell lines.
    Youm I; Youan BB
    Hear Res; 2013 Oct; 304():7-19. PubMed ID: 23747541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
    Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
    Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B; Ranganathan B; Feng SS
    Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular drug delivery in Leishmania-infected macrophages: Evaluation of saponin-loaded PLGA nanoparticles.
    Van de Ven H; Vermeersch M; Vandenbroucke RE; Matheeussen A; Apers S; Weyenberg W; De Smedt SC; Cos P; Maes L; Ludwig A
    J Drug Target; 2012 Feb; 20(2):142-54. PubMed ID: 22080813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.